封面
市場調查報告書
商品編碼
2050820

全球動物生物技術市場:按產品類型、應用、動物種類、最終用戶和地區分類

Global Animal Biotechnology Market, By Product Type, By Application, By Animal Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球動物生物技術市場預計2026年達到344.8億美元,預計2033年將達到642.6億美元。從2026年到2033年,預計其複合年成長率為9.3%,達到642.6億美元。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 344.8億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 9.30% 2033年市場規模預測: 642.6億美元

動物生物技術是利用動物的生物過程和系統來開發和改進特定應用的產品和工藝的技術。這包括旨在生產新藥和疫苗的動物基因工程和克隆技術。畜產品需求的成長以及動物疾病的蔓延,正在推動動物生物技術應用需求的不斷成長。體外受精、人工授精和胚胎移植等技術正在提高畜牧生產的效率和品質。此外,動物克隆技術和幹細胞研究在再生醫學和疾病建模領域的應用也日益廣泛。預計該領域領先企業不斷增加的研發投入將推動全球動物生物技術市場在預測期內實現顯著成長。

市場動態:

全球動物生物技術市場受多種因素驅動,包括動物性蛋白質消費量的成長、通用感染疾病的蔓延以及對基因改造動物日益成長的需求。開發中國家人口成長和人均收入提高推動了肉類和乳製品的需求,進而刺激了動物生物技術領域的研究活動。然而,動物生物技術高昂的研發成本以及動物複製相關的倫理問題限制著該市場的成長。先進生殖技術的開發和幹細胞在畜牧業中日益廣泛的應用,為市場相關人員帶來了充滿希望的商機。

例如,根據美國疾病管制與預防中心 (CDC) 於 2025 年 5 月 15 日發布的報告,通用感染疾病在美國和世界各地非常普遍,據估計,已知的 10 例人類感染疾病中有 6 例是由動物傳播的,4 例新的或新出現的人類感染疾病中有 3 例源於動物。

本研究的主要特點:

  • 該研究揭示了各個細分市場的潛在收入成長機會,並為該市場說明了一個有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數創建了全球動物生物技術市場主要公司的概況:公司亮點、產品系列、主要特徵、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球動物生物技術市場報告的目標受群眾外包括產業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過分析全球動物生物技術市場中使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 動物性蛋白質需求增加
    • 倫理問題阻礙了基因改造動物的商業化。
    • 基因工程的進步正在推動基因治療領域的發展。
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 服務提供組合
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 全球動物生物技術市場:依產品類型分類,2021-2033年

  • 診斷測試
  • 疫苗
  • 製藥
  • 生殖與遺傳
  • 飼料添加劑
  • 其他

第5章 全球動物生物技術市場:依應用領域分類,2021-2033年

  • 動物疾病的診斷
  • 動物疾病的治療
  • 動物預防醫學
  • 藥物研發
  • 其他

第6章 全球動物生物技術市場:依動物類型分類,2021-2033年

  • 伴侶
  • 家畜

第7章 全球動物生物技術市場:依最終用戶分類,2021-2033年

  • 獸醫檢測實驗室
  • 即時檢測/院內檢測
  • 獸醫醫院和診所
  • 其他

第8章 全球動物生物技術市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第9章 競爭情勢

  • Heska Corporation
  • Indian Immunologicals Ltd.
  • HESTER BIOSCIENCES LIMITED
  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH
  • Biogenesis Bago
  • Merck & Co., Inc.
  • Virbac
  • Elanco
  • Cadila Pharma
  • Thermo Fisher Scientific Inc.
  • Idexx Laboratories
  • Randox Laboratories Ltd.
  • Gold Standard Diagnostics.
  • Bionote USA Inc.
  • Meiji Holdings Co., Ltd.
  • Kemin Industries, Inc.
  • Pfizer Inc.

第10章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6555

Global Animal Biotechnology Market is estimated to be valued at USD 34.48 Bn in 2026 and is expected to reach USD 64.26 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.3%USD 64.26 Bn from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 34.48 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.30% 2033 Value Projection: USD 64.26 Bn

Animal biotechnology is the use of biological processes and systems in animals to develop or modify products and processes for specific use. It involves the genetic engineering and cloning of animals for producing new drugs and vaccines. The growing demand for livestock products coupled with the rising prevalence of animal diseases is augmenting the demand for animal biotechnological applications. Techniques such as in-vitro fertilization, artificial insemination, and embryo transfer are improving livestock production efficiency and quality. Moreover, animal cloning and stem cell research are finding applications in regenerative medicine and disease modeling. The global animal biotechnology market is expected to witness significant growth over the forecast period owing to the increasing R&D investments by key players in this field.

Market Dynamics:

The global animal biotechnology market is driven by factors such as increasing consumption of animal-derived proteingeins, rising prevalence of zoonotic diseases, and growing demand for transgenic animals. Growing population and increasing per capita income in developing countries are fueling the demand for meat and dairy products, which is propelling research activities in animal biotechnology. However, high R&D costs associated with animal biotechnology and ethical issues regarding animal cloning are restraining the growth of this market. The development of advanced reproductive techniques and increasing applications of stem cells in livestock production provide lucrative opportunities for market players.

For instance, on May 15, 2025, according to a report published by the Centers for Disease Control and Prevention, zoonotic diseases are very common, both in the U.S. and around the world, while it is estimated that more than six out of every 10 known infectious diseases in people can be spread from animals, and three out of every four new or emerging infectious diseases in people come from animals.

Key features of the study:

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global animal biotechnology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Heska Corporation, Indian Immunologicals Ltd., HESTER BIOSCIENCES LIMITED, Zoetis Inc. , Boehringer Ingelheim International GmbH, Biogenesis Bago, Merck & Co., Inc., Virbac, Elanco, Cadila Pharma, Thermo Fisher Scientific Inc. , Idexx Laboratories, Randox Laboratories Ltd. , Gold Standard Diagnostics. , Bionote USA Inc., Meiji Holdings Co., Ltd., Kemin Industries, Inc., and Pfizer Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global animal biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal biotechnology market

Detailed Segmentation:

  • Global Animal Biotechnology Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
  • Diagnostics Tests
  • Vaccines
  • Drugs
  • Reproductive and Genetic
  • Feed Additives
  • Others
  • Global Animal Biotechnology Market, By Application (Revenue, USD Bn, 2021 - 2033)
  • Diagnosis of Animal Diseases
  • Treatment of Animal Diseases
  • Preventive Care of Animals
  • Drug Development
  • Others
  • Global Animal Biotechnology Market, By Animal Type (Revenue, USD Bn, 2021 - 2033)
  • Companion
    • Dogs
    • Cats
    • Horses
    • Others
  • Livestock
    • Poultry
    • Swine
    • Cattle
    • Sheep & Goats
    • Others
  • Global Animal Biotechnology Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Veterinary Laboratories
  • Point-of-Care Testing/In-house Testing
  • Veterinary Hospitals & Clinics
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Global Animal Biotechnology Market, Key Players
  • Heska Corporation
  • Indian Immunologicals Ltd.
  • HESTER BIOSCIENCES LIMITED
  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH
  • Biogenesis Bago
  • Merck & Co., Inc.
  • Virbac
  • Elanco
  • Cadila Pharma
  • Thermo Fisher Scientific Inc.
  • Idexx Laboratories
  • Randox Laboratories Ltd.
  • Gold Standard Diagnostics.
  • Bionote USA Inc.
  • Meiji Holdings Co., Ltd.
  • Kemin Industries, Inc.
  • Pfizer Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Animal Biotechnology Market, By Product Type
    • Global Animal Biotechnology Market, By Application
    • Global Animal Biotechnology Market, By Animal Type
    • Global Animal Biotechnology Market, By End User
    • Global Animal Biotechnology Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing Demand for Animal Protein
    • Ethical Concerns Hamper Commercialization of Transgenic Animals
    • Advancements in Genetic Engineering Drive the Gene Therapy Segment
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Service Offering Portfolio
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Animal Biotechnology Market, By Product Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diagnostics Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Reproductive and Genetic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Feed Additives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Global Animal Biotechnology Market, By Application, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diagnosis of Animal Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Treatment of Animal Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Preventive Care of Animals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Drug Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Animal Biotechnology Market, By Animal Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Companion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
      • Dogs
      • Cats
      • Horses
      • Others
  • Livestock
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
      • Poultry
      • Swine
      • Cattle
      • Sheep & Goats
      • Others

7. Global Animal Biotechnology Market, By End User, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Veterinary Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Point-of-Care Testing/In-house Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Veterinary Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Global Animal Biotechnology Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Heska Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Indian Immunologicals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • HESTER BIOSCIENCES LIMITED
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biogenesis Bago
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Virbac
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Elanco
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cadila Pharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Idexx Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Randox Laboratories Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Gold Standard Diagnostics.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bionote USA Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Meiji Holdings Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Kemin Industries, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us